The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus

Karen L. Denzler, Amanda D. Rice, Amy L. MacNeill, Nobuko Fukushima, Scott F. Lindsey, Greg Wallace, Andrew M. Burrage, Andrew J. Smith, Brandi R. Manning, Daniele M. Swetnam, Stacey A. Gray, R. W. Moyer, Bertram Jacobs

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Vaccinia virus deleted for the innate immune evasion gene, E3L, has been shown to be highly attenuated and yet induces a protective immune response against challenge by homologous virus in a mouse model. In this manuscript the NYCBH vaccinia virus vaccine strain was compared to NYCBH vaccinia virus deleted for E3L (NYCBHΔE3L) in a rabbitpox virus (RPV) challenge model. Upon scarification, both vaccines produced a desired skin lesion, although the lesion produced by NYCBHΔE3L was smaller. Both vaccines fully protected rabbits against lethal challenge by escalating doses of RPV, from 10LD 50 to 1000LD 50. A single dose of NYCBHΔE3L protected rabbits from weight loss, fever, and clinical symptoms following the lowest dose challenge of 10LD 50, however it allowed a moderate level of RPV replication at the challenge site, some spread to external skin and mucosal surfaces, and increased numbers of secondary lesions as compared to vaccination with NYCBH. Alternately, two doses of NYCBHΔE3L fully protected rabbits from weight loss, fever, and clinical symptoms, following challenge with 100-1000LD 50 RPV, and it prevented development of secondary lesions similar to protection seen with NYCBH. Finally, vaccination with either one or two doses of NYCBHΔE3L resulted in similar neutralizing antibody titers following RPV challenge as compared to titers obtained by vaccination with NYCBH. These results support the efficacy of the attenuated NYCBHΔE3L in protection against an orthologous poxvirus challenge.

Original languageEnglish (US)
Pages (from-to)7659-7669
Number of pages11
JournalVaccine
Volume29
Issue number44
DOIs
StatePublished - Oct 13 2011

Fingerprint

immune evasion
Immune Evasion
Vaccinia virus
lethal genes
rabbits
Rabbits
viruses
lesions (animal)
dosage
Genes
vaccination
vaccines
genes
signs and symptoms (animals and humans)
fever
weight loss
Vaccination
Poxviridae
Vaccines
Weight Loss

Keywords

  • E3L gene
  • Rabbitpox virus
  • Smallpox
  • Vaccinia virus

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus. / Denzler, Karen L.; Rice, Amanda D.; MacNeill, Amy L.; Fukushima, Nobuko; Lindsey, Scott F.; Wallace, Greg; Burrage, Andrew M.; Smith, Andrew J.; Manning, Brandi R.; Swetnam, Daniele M.; Gray, Stacey A.; Moyer, R. W.; Jacobs, Bertram.

In: Vaccine, Vol. 29, No. 44, 13.10.2011, p. 7659-7669.

Research output: Contribution to journalArticle

Denzler, KL, Rice, AD, MacNeill, AL, Fukushima, N, Lindsey, SF, Wallace, G, Burrage, AM, Smith, AJ, Manning, BR, Swetnam, DM, Gray, SA, Moyer, RW & Jacobs, B 2011, 'The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus', Vaccine, vol. 29, no. 44, pp. 7659-7669. https://doi.org/10.1016/j.vaccine.2011.07.140
Denzler, Karen L. ; Rice, Amanda D. ; MacNeill, Amy L. ; Fukushima, Nobuko ; Lindsey, Scott F. ; Wallace, Greg ; Burrage, Andrew M. ; Smith, Andrew J. ; Manning, Brandi R. ; Swetnam, Daniele M. ; Gray, Stacey A. ; Moyer, R. W. ; Jacobs, Bertram. / The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus. In: Vaccine. 2011 ; Vol. 29, No. 44. pp. 7659-7669.
@article{6aa86d1e2d3249428b184bc3a289f014,
title = "The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus",
abstract = "Vaccinia virus deleted for the innate immune evasion gene, E3L, has been shown to be highly attenuated and yet induces a protective immune response against challenge by homologous virus in a mouse model. In this manuscript the NYCBH vaccinia virus vaccine strain was compared to NYCBH vaccinia virus deleted for E3L (NYCBHΔE3L) in a rabbitpox virus (RPV) challenge model. Upon scarification, both vaccines produced a desired skin lesion, although the lesion produced by NYCBHΔE3L was smaller. Both vaccines fully protected rabbits against lethal challenge by escalating doses of RPV, from 10LD 50 to 1000LD 50. A single dose of NYCBHΔE3L protected rabbits from weight loss, fever, and clinical symptoms following the lowest dose challenge of 10LD 50, however it allowed a moderate level of RPV replication at the challenge site, some spread to external skin and mucosal surfaces, and increased numbers of secondary lesions as compared to vaccination with NYCBH. Alternately, two doses of NYCBHΔE3L fully protected rabbits from weight loss, fever, and clinical symptoms, following challenge with 100-1000LD 50 RPV, and it prevented development of secondary lesions similar to protection seen with NYCBH. Finally, vaccination with either one or two doses of NYCBHΔE3L resulted in similar neutralizing antibody titers following RPV challenge as compared to titers obtained by vaccination with NYCBH. These results support the efficacy of the attenuated NYCBHΔE3L in protection against an orthologous poxvirus challenge.",
keywords = "E3L gene, Rabbitpox virus, Smallpox, Vaccinia virus",
author = "Denzler, {Karen L.} and Rice, {Amanda D.} and MacNeill, {Amy L.} and Nobuko Fukushima and Lindsey, {Scott F.} and Greg Wallace and Burrage, {Andrew M.} and Smith, {Andrew J.} and Manning, {Brandi R.} and Swetnam, {Daniele M.} and Gray, {Stacey A.} and Moyer, {R. W.} and Bertram Jacobs",
year = "2011",
month = "10",
day = "13",
doi = "10.1016/j.vaccine.2011.07.140",
language = "English (US)",
volume = "29",
pages = "7659--7669",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "44",

}

TY - JOUR

T1 - The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus

AU - Denzler, Karen L.

AU - Rice, Amanda D.

AU - MacNeill, Amy L.

AU - Fukushima, Nobuko

AU - Lindsey, Scott F.

AU - Wallace, Greg

AU - Burrage, Andrew M.

AU - Smith, Andrew J.

AU - Manning, Brandi R.

AU - Swetnam, Daniele M.

AU - Gray, Stacey A.

AU - Moyer, R. W.

AU - Jacobs, Bertram

PY - 2011/10/13

Y1 - 2011/10/13

N2 - Vaccinia virus deleted for the innate immune evasion gene, E3L, has been shown to be highly attenuated and yet induces a protective immune response against challenge by homologous virus in a mouse model. In this manuscript the NYCBH vaccinia virus vaccine strain was compared to NYCBH vaccinia virus deleted for E3L (NYCBHΔE3L) in a rabbitpox virus (RPV) challenge model. Upon scarification, both vaccines produced a desired skin lesion, although the lesion produced by NYCBHΔE3L was smaller. Both vaccines fully protected rabbits against lethal challenge by escalating doses of RPV, from 10LD 50 to 1000LD 50. A single dose of NYCBHΔE3L protected rabbits from weight loss, fever, and clinical symptoms following the lowest dose challenge of 10LD 50, however it allowed a moderate level of RPV replication at the challenge site, some spread to external skin and mucosal surfaces, and increased numbers of secondary lesions as compared to vaccination with NYCBH. Alternately, two doses of NYCBHΔE3L fully protected rabbits from weight loss, fever, and clinical symptoms, following challenge with 100-1000LD 50 RPV, and it prevented development of secondary lesions similar to protection seen with NYCBH. Finally, vaccination with either one or two doses of NYCBHΔE3L resulted in similar neutralizing antibody titers following RPV challenge as compared to titers obtained by vaccination with NYCBH. These results support the efficacy of the attenuated NYCBHΔE3L in protection against an orthologous poxvirus challenge.

AB - Vaccinia virus deleted for the innate immune evasion gene, E3L, has been shown to be highly attenuated and yet induces a protective immune response against challenge by homologous virus in a mouse model. In this manuscript the NYCBH vaccinia virus vaccine strain was compared to NYCBH vaccinia virus deleted for E3L (NYCBHΔE3L) in a rabbitpox virus (RPV) challenge model. Upon scarification, both vaccines produced a desired skin lesion, although the lesion produced by NYCBHΔE3L was smaller. Both vaccines fully protected rabbits against lethal challenge by escalating doses of RPV, from 10LD 50 to 1000LD 50. A single dose of NYCBHΔE3L protected rabbits from weight loss, fever, and clinical symptoms following the lowest dose challenge of 10LD 50, however it allowed a moderate level of RPV replication at the challenge site, some spread to external skin and mucosal surfaces, and increased numbers of secondary lesions as compared to vaccination with NYCBH. Alternately, two doses of NYCBHΔE3L fully protected rabbits from weight loss, fever, and clinical symptoms, following challenge with 100-1000LD 50 RPV, and it prevented development of secondary lesions similar to protection seen with NYCBH. Finally, vaccination with either one or two doses of NYCBHΔE3L resulted in similar neutralizing antibody titers following RPV challenge as compared to titers obtained by vaccination with NYCBH. These results support the efficacy of the attenuated NYCBHΔE3L in protection against an orthologous poxvirus challenge.

KW - E3L gene

KW - Rabbitpox virus

KW - Smallpox

KW - Vaccinia virus

UR - http://www.scopus.com/inward/record.url?scp=80053592198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053592198&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2011.07.140

DO - 10.1016/j.vaccine.2011.07.140

M3 - Article

VL - 29

SP - 7659

EP - 7669

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 44

ER -